Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...
Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
Futurism on MSN1d
Mounjaro Appears to Be Extremely Effective at Preventing DiabetesA new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...
Health stocks slumped on Friday as Wall Street weighed the impact that prominent vaccine skeptic Robert F. Kennedy Jr. could ...
Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...
Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.
On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks. They ...
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...
The classical understanding of personal autonomy, which still influences medical guidelines, is based on an individualistic framework and is inadequate for ethical mental health care. The goal of ...
Q&A: OrthoIndy’s John Ryan talks about staying independent in a consolidating health care industry
John Ryan leads Indiana’s largest orthopedic medical group, OrthoIndy, with more than 100 physicians and 1,200 employees at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback